| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f4552bec9a852244269a330fda1c754
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bc5292a07e34d16eb1d033a16d3aec3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7659d4abda44bced13b5edc01e96aab |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B29-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-30 |
| filingDate |
2017-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e71d7143c047b36b70f64c784e23a374
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2ce623198e73254ff1ae22f7ac8e7e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b4c68a7db6cbcefcc4123872bdd1ae7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91c7de7aee1b93779dc83cde482f2552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a89d8c1eafe60d7680e123012118f52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b6307929687d46eec828037244e0116 |
| publicationDate |
2018-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018014091-A1 |
| titleOfInvention |
Insulin analogs |
| abstract |
The present invention relates to insulin analogs, particularly insulin analogs having shortened B chains. The present invention also relates to the crystal structure of insulin from the venom of cone snails and to methods of using the crystal and related structural information to screen for and design insulin analogs that interact with or modulate the insulin receptor. The present invention also relates to therapeutic and prophylactic methods using insulin analogs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114675019-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114675019-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155804-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11492650-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018187568-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11248034-B2 |
| priorityDate |
2016-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |